The lawmakers wrote, in part: "Diabetes is one of our country's most expensive diseases in both human and economic terms, affecting people of all ages and races, and in every region of our country [...] Although the costs and prevalence of diabetes continue to increase, the SDP is making meaningful progress. The SDP comprises two partner components: the Special Statutory Funding Program for Type 1 Diabetes Research (SDP) and the Special Diabetes Program for Indians (SDPI). Since the program's inception, both components have delivered critical resources and research breakthroughs for the more than 40 million Americans with diabetes and 115.2 million with prediabetes, as well as their loved ones."